Navigation Links
Edwards Lifesciences Chief Medical Officer to Keynote the Inaugural MedTech Cardio 2012 Conference at the MD&M Minneapolis Exposition and Conference
Date:8/23/2012

LOS ANGELES, August 23, 2012 /PRNewswire/ --

The MD&M Minneapolis exposition and conference for medical devices this year will feature the MedTech Cardio conference, specifically designed for the cardiovascular device manufacturing audience. The conference will address key issues in cardiovascular device design and manufacturing. MedTech Cardio takes place over two days on October 30 and 31, 2012 at the Minneapolis Convention Center, alongside our MD&M event. For more information, visit http://www.medtechcardio.com

"As the largest and fastest-growing sector of medical equipment, the cardiovascular device industry is bolstered by key trends such as the world's aging population, new therapeutic areas, and rapid technological advances in materials, design and technologies. The sector is not without challenges, however. Cardiovascular devices' high-risk profile impacts every aspect of product development and manufacturing. Meticulously assessing and effectively mitigating risk can be a daunting task. MedTech Cardio is a forum tailored to the designers and makers of cardiovascular devices created to provide practical information to overcome the challenges faced by the industry on a daily basis," said Brian Buntz, Editor-at-Large, MD+DI and Conference Chair at MedTech Cardio.  

"MedTech Cardio gathers a highly selective group of more than 20 speakers who are industry leaders, experts and visionaries in the cardiovascular device field," said Vu Nguyen, Conference Program Director. Participants will join 19+ sessions covering the most critical issues in the development and manufacturing of next-generation cardiovascular devices. Unlike other cardiology conferences, this unique meeting is geared towards R&D, Product Development, Process Development, Engineering, Quality Control, and Business Development professionals at medtech companies that are focused on cardiovascular device manufacturing.

Dr. Francis Duhay, Chief Medical Officer at Edwards Lifesciences, will give a keynote speech on the overview of the cardiovascular device industry and major market trends. Some notable speakers joining Dr. Duhay include Dr. Peter Fitzgerald-a renowned cardiologist-inventor from Stanford University and a member of the FDA Medical Device Advisory Board, Josiah Wilcox-Chief Scientific Officer for the CardioVascular Group at Medtronic, Bridget Hurley-Director of R&D at Abbott Vascular, Sanjeev Kulkarni-R&D Fellow at Boston Scientific, and Dr. Dave Albert-Founder of AliveCor and Former Chief Clinical Scientist at GE Cardiology. For a full list of the speaking faculty at MedTech Cardio, visit http://www.medtechcardio.com  

Topics at MedTech Cardio 2012 include:

  • FDA compliance, updates on 510(k) and user fees for high-risk cardiovascular devices
  • Recently proposed UDI rules, track-and-trace capabilities for quality control
  • Biomaterial trends, biocompatibility of materials, new biomedical woven textiles
  • ASTM test methods and computer modeling systems for risk management and quality control
  • Nanotechnology and future DES design, ePTFE coating technique
  • Cardiovascular regeneration/tissue engineering
  • Sensor-enhanced CRMs and minimally invasive catheters
  • Consumerization of cardiovascular devices

MedTech Cardio (http://www.medtechcardio.com) is developed by MD&M (http://www.canontradeshows.com), and in association with MD+DI (http://www.mddinonline.com), a leading publication for OEMs of medical devices and diagnostic products. MedTech Cardio 2012 is co-located with the MD&M Minneapolis tradeshow and conference. For more information about the MD&M Minneapolis event, visit http://www.mdmminn.com. Cite code MJ when registering.

Contact:
Vu Nguyen
vu.nguyen@ubm.com
+1-310-996-9495


'/>"/>
SOURCE UBM Canon
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Marshall Edwards Announces Name Change to MEI Pharma ("MEIP")
2. Marshall Edwards Announces First Cohort Of Patients Dosed In Phase I Clinical Trial Of Oncology Drug Candidate ME-344
3. Novogen Board Approves US$4 Million Investment In Marshall Edwards Rights Offering
4. Marshall Edwards Receives $4 Million Subscription From Novogen In Rights Offering
5. Biodel to Present at 2012 Wedbush PacGrow Lifesciences Management Access Conference
6. HeartWare Presentation at the 2012 Wedbush PacGrow Lifesciences Management Access Conference to be Webcast
7. BioDelivery Sciences to Present at the 2012 Wedbush PacGrow Lifesciences Management Access Conference
8. Landauer, Inc. Appoints Ronald Zilkowski To Vice President, Corporate Controller And Chief Accounting Officer
9. BioMotiv Names New Chief Executive Officer
10. ChanTest hires Chris Mathes as Chief Commercial Officer
11. Doug Pepper appointed as Chief Financial Officer at Cardiac Science
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2020)... ... June 23, 2020 , ... Today ... one of the first online COVID-19 trainings for health workers and others on ... free training entitled COVID-19 Training for Health Workers: Preparedness and Response ...
(Date:6/23/2020)... ... June 23, 2020 , ... ... "Company"), a leading provider of center-based, Applied Behavioral Analysis ("ABA") therapy, today ... ABA provider in the greater-Indianapolis market. This acquisition will make Lighthouse Autism ...
(Date:6/23/2020)... ... June 23, 2020 , ... Award-winning digital product design ... with over 60 million users, to build a COVID-19 map . The goal ... to date clarity through easy-to-understand data and visuals on the current COVID-19 situation both ...
Breaking Medicine Technology:
(Date:7/2/2020)... ... 2020 , ... Allegheny Health Network (AHN) today announced that John S. Lee, ... immediately. Dr. Lee succeeds Robert White, MD, who announced his plans for retirement ... year to help support a seamless transition. , Dr. Lee joins AHN from Edward-Elmhurst ...
(Date:7/1/2020)... ... July 01, 2020 , ... ... the clinical development of psychedelics and analogues, announces its core executive team. The ... natural product drug discovery, novel formulations, and as distinguished researchers within the cannabis ...
(Date:6/28/2020)... ... , ... Medisend College of Biomedical Engineering Technology, a Dallas-based ... prepares graduates for professional careers as field service engineers and biomedical equipment technicians, ... Ms. Williams currently serves as Associate Vice Chancellor of Workforce and Community Initiatives ...
(Date:6/28/2020)... , ... June 27, 2020 , ... The secret of ... of hundreds of rolls of toilet paper. Yet, it was the first product to ... sensible in theory. The more you have stockpiled, the less need to venture out, ...
(Date:6/25/2020)... ... , ... Denials Management, Inc. has just published The Health Insurance Appeals Guide ... denials of mental health and substance use disorder (MH/SUD) treatment services. It was written ... explain the steps in the appeals process. Complimentary copies of the Guide can ...
Breaking Medicine News(10 mins):